Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Go back to Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
(AMEX: VSQTF) Delayed: 0.37 -0.01 (2.63%)
Previous Close $0.38    52 Week High
Open $0.38    52 Week Low
Day High $0.39    P/E N/A 
Day Low $0.36    EPS
Volume 90,983       

(NYSE: VST) Delayed: 140.67 -2.89 (2.01%)
Previous Close $143.56    52 Week High
Open $143.40    52 Week Low
Day High $144.45    P/E N/A 
Day Low $140.21    EPS
Volume 5,266,383